Back to search results

Collaborative Care for Depression and Anxiety

This study is looking at how well a program called Collaborative Care works for people with depression and/or anxiety who receive care at Kaiser Permanente Colorado. Collaborative Care involves a team approach to your care, using short-term treatments delivered over the phone. Researchers want to see if this approach improves your symptoms of depression (measured by the PHQ-9 score) and anxiety (measured by the GAD-7 score) over 24 weeks. You might be able to join if you are 18 or older, have a depression diagnosis from the past year, and are overdue for a PHQ-9 screening. The study's current status is unclear.

Study design
This is an observational study involving 200 participants, comparing clinics that offer collaborative care to those that do not.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your depression and anxiety symptoms will be measured at the start of the study and for up to 24 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06556589

Collaborative Care for Treatment of Depression and Anxiety

UNKNOWN
Not specifiedAges 18+Observational
Kaiser Permanente
~200 participants
Updated 2024-08-16 on ClinicalTrials.gov
What's tested:Collaborative Care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Health Questionnaire 9-item (PHQ-9) score
Measured over Baseline and up to 24 weeks
+1 more outcome measured

Conditions

Depression
Anxiety

Explore related trials

AnxietyDepression

NCT06556589

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Kaiser Permanente Colorado

    Aurora, Coloradostudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Arne Beck, PhD
[email protected]
720-989-5181
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18+
Current membership and active on patient portal
Depression Diagnosis in the prior year
Overdue for PHQ9 Screening based on the following criteria:
High Risk: Last PHQ9 screener was completed greater than 4 months ago AND total Score is greater than or equal 10 or item 9 is greater than 0.
Low Risk: Last PHQ9 screener was completed greater than 12 months ago AND Last PHQ9 Total Score is less than 10 and item 9 is equal to 0.
Anxiety diagnoses in the prior year
Has a baseline GAD7 in the same prior year; score = 10+ (\*Note: Provider referrals could be GAD7 score of 7 or higher)
No Behavioral Health (BH) engagement in the prior year
Patient is not in a Skilled Nursing Facility or Hospice
Patient has no record of psychiatric hospitalization in the last year
Patient does not need an interpreter (i.e., English speaking)
Primary care location is one of the intervention clinics

Exclusion

Psychosis
Dementia
Bipolar
Personality Disorders
Post Traumatic Stress Disorder (PTSD)
Obsessive Compulsive Disorder (OCD)
Panic Disorder
Cognitive Disorder

What this trial measures

  • Patient Health Questionnaire 9-item (PHQ-9) scoreBaseline and up to 24 weeks

    Change in Patient Health Questionnaire 9-item (PHQ-9) scores before and after Collaborative Care intervention. The score ranges from 0 to 27, with lower numbers indicating improvement in depression symptoms.

  • Generalized Anxiety Disorder 7-item (GAD-7)Baseline and up to 24 weeks

    Generalized Anxiety Disorder 7-item (GAD-7) questionnaire scores before and after Collaborative Care intervention. The score ranges from 0 to 21, with lower numbers indicating improvement in anxiety symptoms.